Issues & Advocacy

SNMMI's mission with regard to health policy and regulatory affairs is to enhance its credibility, advance its issues, and through leadership become a valued partner among public policy stakeholders.


  • August 3, 2021CMS Revokes Coding Barriers for 18F FDG PET Infection and Inflammation NCD Retirement
    In December 2020, CMS retired the National Coverage Determination for F-18 FDG PET for infection and inflammation, effective January 1, 2021. On June 8, CMS put forth certain ICD-10 codes for osteomyelitis and fever of unknown origin in a transmittal—which they would NOT cover. Yesterday, that decision was reversed.
  • July 26, 2021SNMMI Comments on CURES 2.0 Proposal
    When Reps. Upton and DeGette requested comment on their 21st Century Cures 2.0 proposal, we listened. The bill aims to continue the acceleration of the discovery, development, and delivery of 21st century cures. The coalition's letter urged Congress to use this opportunity to expand Medicare beneficiary access to diagnostic radiopharmaceuticals.
  • July 21, 2021SNMMI and Coalition Partners Applaud the Introduction of the FIND Act
    On July 16, Congressmen Scott Peters (D-CA), Bobby Rush (D-IL), Neal Dunn (R-FL) and Greg Murphy (R-NC) introduced the Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021 (H.R. 4479), legislation that would significantly expand patient access to advanced nuclear diagnostic imaging technologies.
  • July 19, 2021CMS Announcements Hold Big Surprises for PET Scans
    Last week brought two big announcements from CMS: a national coverage analysis notice on Alzheimer's disease treatment and the Medicare Physician Fee Schedule (MPFS).
  • June 29, 2021California Members: Act Now to Oppose A.B 1273
    Earlier this year, Assemblyman Freddie Rodriguez introduced A.B 1273, Interagency Advisory Committee on Apprenticeship: the Director of Consumer Affairs and the State Public Health Officer. Our SNMMI-TS Advocacy Committee acted quickly and submitted an opposition letter prior to the public hearing before the Health Committee. This harmful piece of legislation is now in California's Senate Appropriations Committee, so we are calling our members to act quickly to oppose it.
  • June 24, 2021SNMMI Submits Senate Testimony Supporting Additional NIH Funding
    Yesterday, SNMMI filed its Outside Witness Testimony in support of increased funding for the National Institutes of Health. In it, the Society continues to promote at least $46.1 billion for NIH.
  • June 21, 2021Update: Humana Reverses Non-Oncologic PET/CT Non-Coverage Policy
    Months ago, Humana reversed its decision to deny coverage for PET/CT imaging of gastric and esophageal oncologic indications. Now we have more good news.
  • June 9, 2021SNMMI Will Engage with CMS to Ensure Coverage of Amyloid PET Imaging
    The FDA approved aducanumab on June 7, but amyloid PET scans were not mentioned as a requirement on the drug label. SNMMI will engage with CMS to ensure access and reimbursement for this important diagnostic test.

  • Click For More Government Relations News